OPN-305
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for OPN-305, covering 2017-02-16 to 2019-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome [Phase 1, Phase 2]